Background A 39-year-old man presented with a history of several months of progressive personality changes, social withdrawal, bradykinesia, mutism, dysphagia, worsening gait, and difficulty with ...
Alert Mirati's Lung Cancer Drug Gets EU's Regulatory Backing Mirati Therapeutics said on Friday the European medicines regulator's panel has recommended approval of its treatment for a type of lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback